TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Graft-Versus-Host Disease
Research on graft-versus-host disease described by M. Hamadani and colleagues
March 25th, 2008
"Immunosuppression and chronic graft-versus-host disease (GVHD) are major risk factors for the development of invasive pulmonary aspergillosis in bone marrow transplant patients," investigators in the United States report. "Although nocardial infections are well described in hematopoietic stem cell transplantation (HSCT) recipients, little information is available about the incidence of nocardiosis in patients with chronic GVHD after HSCT. Coexistence of invasive pulmonary aspergillosis and nocardiosis following non-myeloablative HSCT has not been reported previously," wrote M. Hamadani and colleagues. The researchers concluded: "With the increasing...
Source: TB & Outbreaks Week (2008-03-25)
|
